Good morning, Broadsheet readers! Elizabeth Holmes's prison sentence is set to begin today, a female director wins at Cannes, and GSK's Emma Walmsley doesn't believe in "superhero" CEOs. Have a splendid Tuesday.
- Thick-skinned. Six weeks after Emma Walmsley became CEO of U.K. drugmaker GlaxoSmithKline in 2017, British fund manager Neil Woodford staged what became known as “Glaxit.” Frustrated with GSK’s “suboptimal business strategy,” he dumped GSK stock entirely. Walmley’s appointment seemed to be the last straw; he deemed the L’Oreal alum a “continuity candidate.”
